Edition:
United Kingdom

Fortress Biotech Inc (FBIO.OQ)

FBIO.OQ on NASDAQ Stock Exchange Capital Market

1.86USD
22 Mar 2019
Change (% chg)

$-0.12 (-6.06%)
Prev Close
$1.98
Open
$1.95
Day's High
$1.95
Day's Low
$1.84
Volume
55,571
Avg. Vol
132,530
52-wk High
$5.25
52-wk Low
$0.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.58 December 23 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 6.41 6.41 6.41 --
Quarter Ending Jun-19 1 6.37 6.37 6.37 --
Year Ending Dec-19 1 27.30 27.30 27.30 206.80
Year Ending Dec-20 1 28.30 28.30 28.30 215.60
Earnings (per share)
Quarter Ending Mar-19 1 -0.58 -0.58 -0.58 --
Quarter Ending Jun-19 1 -0.57 -0.57 -0.57 --
Year Ending Dec-19 1 -2.28 -2.28 -2.28 -2.23
Year Ending Dec-20 1 -2.49 -2.49 -2.49 -2.33

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 64.88 63.69 1.19 1.83
Quarter Ending Jun-18 48.93 63.83 14.90 30.46
Quarter Ending Mar-18 49.29 55.42 6.13 12.45
Quarter Ending Dec-17 48.03 45.32 2.71 5.64
Quarter Ending Sep-17 50.75 46.89 3.86 7.61

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 6.41 63.32 63.32 -- --
Quarter Ending Jun-19 6.37 5.48 5.48 -- --
Year Ending Dec-19 27.30 81.80 81.80 255.70 206.80
Year Ending Dec-20 28.30 24.70 24.70 260.80 215.60

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 1 0 1
Quarter Ending Jun-19 1 0 1 0
Year Ending Dec-19 0 1 0 1
Year Ending Dec-20 1 0 1 0
Earnings